By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


SEARCH JOBS








Company News
BioTime (BTX) Subsidiary OncoCyte Corporation Completes Initial Enrollment Of Clinical Study Of Urine-Based Bladder Cancer Diagnostic 12/16/2014 11:48:21 AM
BioTime (BTX) Subsidiary ES Cell International Pte Ltd. And GE Healthcare Cross-License Patents In The Field Of Cell Assays For Drug Testing 12/16/2014 11:36:29 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Completes Initial Enrollment Of Clinical Study Of Urine-Based Bladder Cancer Diagnostic 12/15/2014 10:08:35 AM
BioTime (BTX) Appoints Angus C. Russell To Board Of Directors 12/15/2014 8:42:44 AM
BioTime (BTX) To Host Investor And Analyst Day On December 15, 2014 12/15/2014 8:34:14 AM
LifeMap Sciences, A Subsidiary Of BioTime (BTX), Announces Release Of MalaCards Version 1.07 With Additional Types Of Clinical Significance From Clinvar And New Phenotypes From HPO 12/12/2014 10:30:54 AM
BioTime (BTX) To Present At The LD Micro VII Conference 12/4/2014 3:09:54 PM
BioTime (BTX) Reports Third Quarter Results And Recent Progress 11/10/2014 10:23:25 AM
BioTime (BTX) Receives Authorization To Begin Pivotal Human Clinical Trial Of Renevia™ In Europe 11/4/2014 10:37:22 AM
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Receives FDA Authorization To Initiate Phase 1/2a Trial Of Embryonic Stem Cell-Derived Opregen® For The Treatment Of The Dry Form Of Age-Related Macular Degeneration 11/3/2014 12:19:14 PM
12345678910...
//-->